Cite
HARVARD Citation
Elumalai, T. et al. (2022). Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel. Clinical oncology. 34 (7), pp. e291-e297. [Online].